The way we currently manufacture our goods is becoming increasingly unsustainable. The established centralised, off-shore, mass production approach is increasingly under threat from global economic volatility, political and security risks, international pandemics and climate change. Watch the video and find out what solutions Redistributed Manufacturing can offer to commonly faced challenges.

For more videos, our past funded feasibilities covered (I) cell microfactories for both autologous and allogeneic CATBTs; (II) 3D bioprinting of islet micro-tissues; commercialisation of ATMP/Device combination products, (III) 3D printing of a diagnostic medical device, and (IV) pharmaceutical products and supply chains. Click the button below to watch now.